Bharat Neeti

BHARAT NEETI

Be Ahead With Economy And Policy Updates

BHARAT NEETI

Be Ahead With Economy And Policy Updates

Torrent Pharma

Torrent Pharma launches oral and injectable formulations of Semaglutide

New Delhi: Torrent Pharmaceuticals today announced the launch of its Semaglutide brands – Sembolic and Semalix – in India, in both oral and injectable formulations. The launch expands the company’s presence in metabolic disorders such as type-2 diabetes and obesity. Commenting on the launch, Amal Kelshikar, CEO – India Business, Torrent Pharma, said: “Metabolic disorders represent one of the most significant healthcare challenges in India with a significant portion of our population affected by Type-2 Diabetes. Our entry into the GLP-1 therapy segment reflects Torrent’s commitment to expanding treatment options

Read More
Advertisement

Web stories